Deutsche Bank Reiterates “€40.00” Price Target for Evonik Industries (EVK)
A number of other research firms have also weighed in on EVK. Goldman Sachs Group set a €29.00 ($34.52) target price on Evonik Industries and gave the company a neutral rating in a report on Wednesday, October 11th. Nord/LB set a €31.00 ($36.90) target price on Evonik Industries and gave the company a neutral rating in a report on Friday, November 3rd. DZ Bank reaffirmed a neutral rating on shares of Evonik Industries in a report on Friday, November 3rd. Independent Research set a €30.00 ($35.71) target price on Evonik Industries and gave the company a neutral rating in a report on Tuesday, August 8th. Finally, Kepler Capital Markets set a €31.00 ($36.90) target price on Evonik Industries and gave the company a neutral rating in a report on Thursday, October 5th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of Buy and an average target price of €34.01 ($40.48).
Evonik Industries (EVK) opened at €32.84 ($39.09) on Monday. Evonik Industries has a twelve month low of €25.74 ($30.64) and a twelve month high of €32.97 ($39.25).
WARNING: “Deutsche Bank Reiterates “€40.00” Price Target for Evonik Industries (EVK)” was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://theolympiareport.com/2017/12/07/deutsche-bank-reiterates-40-00-price-target-for-evonik-industries-evk.html.
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries AG and related companies with Analyst Ratings Network's FREE daily email newsletter.